Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro

FS Chen, YZ Cui, RC Luo - Nan Fang yi ke da xue xue bao= Journal …, 2008 - europepmc.org
Objective To investigate the inhibitory effect of sorafenib in combination with cisplatin (DDP)
on the proliferation of hepatocellular carcinoma cells and explore the molecular …
被引用次数：8 相关文章

Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro

F CHEN, Y CUI, R LUO, J WU… - Journal of Southern …, 2008 - pesquisa.bvsalud.org
ABSTRACT< p>< b> OBJECTIVE</b> To investigate the inhibitory effect of sorafenib in
combination with cisplatin (DDP) on the proliferation of hepatocellular carcinoma cells and …

Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro

F Chen, Y Cui, R Luo, J Wu… - Nan fang yi ke da xue …, 2008 - pubmed.ncbi.nlm.nih.gov
Objective To investigate the inhibitory effect of sorafenib in combination with cisplatin (DDP)
on the proliferation of hepatocellular carcinoma cells and explore the molecular …

Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro.

F Chen, Y Cui, R Luo, WU Jing… - Journal of Southern …, 2008 - wprim.whocc.org.cn
Western Pacific Region Index Medicus 中文 | English Western Pacific Region Index Medicus
Home | Help | Contact Return Coadministration of sorafenib and cisplatin inhibits proliferation …